Chromosome segregation errors: a double-edged sword - TI Pharma
Chromosome segregation errors: a double-edged sword - TI Pharma
Chromosome segregation errors: a double-edged sword - TI Pharma
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2.2 Benefits of being CIN<br />
Generally, CIN is thought to be able to promote tumorigenesis by inducing loss of certain tumor<br />
suppressor genes or gain of oncogenes. Loss of heterozygosity could reveal certain mutations in<br />
tumor suppressor genes and therefore promote a transforming event 634 . In line with this, crossing<br />
a CIN mouse model carrying a hypomorphic Bub1 allele with several tumor-prone mouse models<br />
resulted in the loss of tumor suppressor genes, such as p53 and APC 286 . <strong>Chromosome</strong> <strong>segregation</strong><br />
<strong>errors</strong> could indeed be quite effective in inducing LOH, since it will immediately induce loss of multiple<br />
genes. However, the induction of aneuploidy is very likely to be detrimental to cells 292,294,445,446 and<br />
it is therefore thought that coinciding mutations would have to arise in other pathways to render<br />
cells insensitive to changes in chromosome number. Examples of such mutations are loss of p53<br />
function 431 or mutations that promote proteasomal degradation in order to circumvent the increases<br />
in protein production obtained by gains of chromosomes 538 . These mutations on their turn could<br />
allow the induction of other transforming changes, which ultimately could lead to tumorigenesis.<br />
Another interesting hypothesis on how CIN and aneuploidy could promote tumorigenesis is through<br />
the creation of a mutator phenotype 281,635 . Aneuploidy could, by changing levels of certain DNA repair<br />
genes, promote an increase in genomic instability. In line with this hypothesis, aneuploidy was initially<br />
found to correlate with genomic instability in cancer cells 617 and has recently been shown to indeed<br />
induce genomic instability in budding yeast 388 . Moreover, CIN could itself be a mutator by inducing<br />
DNA damage and structural chromosomal changes through micronuclei formation 390 or cleavage<br />
furrow ingression in the presence of lagging chromosomes (Chapter 2). Interestingly, crossing a CIN<br />
mouse model with a mouse model deficient for the DNA damage checkpoint kinase ATM resulted<br />
in accelerated tumor formation 407 , suggesting that loss of DNA damage checkpoint activation could<br />
promote CIN-induced tumor formation, again supporting a role for CIN in promoting genomic instability.<br />
Interestingly, CIN and defects in mismatch repair, which result in microsatellite instability (MIN), were<br />
found to be almost always mutually exclusive in colon carcinoma cells 270 . MIN tumor cells are near<br />
diploid, indicating that aneuploidy is not simply a bystander of tumor formation 270 . In contrast to<br />
MIN cells, CIN cells rarely obtain mismatch repair deficiencies, but are always aneuploid, suggesting<br />
that CIN and MIN each support a distinct mutator phenotype driving cancer progression 231 .<br />
In summary, CIN and aneuploidy could together create an environment in which cancer cells<br />
continuously lose and gain whole chromosomes, but also gain mutations or translocations, which<br />
interfere with the function of genes involved in DNA repair, mitotic fidelity and cell cycle progression,<br />
therefore promoting transformation of cells or conferring resistance to chemotherapeutics.<br />
2.3 Future of CIN research<br />
The question remains whether CIN is an initiator of tumorigenesis, whether it mainly provides an<br />
enhancing effect to promote transformation or if it is a mere consequence of tumor formation.<br />
The fact that CIN is a common trait of over 70% of all tumors makes it unlikely to simply be a<br />
bystander of tumorigenesis. Whole genome sequencing of early neoplasia in either tumorprone<br />
mouse models or human patients in combination with assessment of CIN status could provide<br />
answers to the question whether CIN has an initiating or enhancing role in tumorigenesis.<br />
The presence of CIN or aneuploidy in early neoplasia in the absence of any other mutations,<br />
would suggest that CIN is an initiating event. In contrary, frequent mutations in certain<br />
oncogenes or tumor suppressor genes in the absence of any CIN, would suggest that<br />
CIN occurs later during tumor development and is rather an enhancer of tumorigenesis.<br />
Ideally, mitotic progression or aneuploidy status would be visualized live in mouse models for spontaneous<br />
155<br />
Discussion<br />
8